A1 adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice
Author(s) -
Bunyen Teng,
Jonathan D. Smith,
Michael E. Rosenfeld,
Peggy Robinet,
Mary E. Davis,
R. Ray Morrison,
S. Jamal Mustafa
Publication year - 2014
Publication title -
cardiovascular research
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvu033
Subject(s) - apolipoprotein e , endocrinology , medicine , apolipoprotein b , triglyceride , lesion , adenosine receptor , aorta , cholesterol , ldl receptor , receptor , biology , lipoprotein , pathology , disease , agonist
The goal of this study was to determine whether the A1 adenosine receptor (AR) plays a role in atherosclerosis development and to explore its potential mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom